---

title: "Haptoglobin phenotypes and structural variants associate with post-exertional malaise and cognitive dysfunction in myalgic encephalomyelitis"
tags:
- üß™ Biomarker
- ‚≠ê Landmark
created: '2025-08-28'
published: '2025-08-28'

---


<details>
<summary>Moezzi et al. (2025)</summary>

- **Authors:** Atefeh Moezzi, Anastasiya Ushenkina, Anna Widgren, Jonas Bergquist, Peng Li, Wenzhong Xiao, Bita Rostami-Afshari, Corinne Leveau, Wesam Elremaly, Iurie Caraus, Anita Franco, Christian Godbout, Oleg Nepotchatykh, Alain Moreau.
- **Institutes:** Department of Biochemistry and Molecular Medicine, Faculty of Medicine, Universit√© de Montr√©al, Montreal, QC, Canada; Viscogliosi Laboratory in Molecular Genetics of Musculoskeletal Diseases, Azrieli Research Center, CHU Sainte-Justine, Montreal, QC, Canada; Open Medicine Foundation ME/CFS Collaborative Center at CHU Sainte-Justine/Universit√© de Montr√©al, Montreal, QC, Canada; ICanCME Research Network, Azrieli Research Center, CHU Sainte-Justine, Montreal, QC, Canada; Analytical Chemistry and Neurochemistry, Department of Chemistry - BMC, Uppsala University, Uppsala, Sweden; The Open Medicine Foundation ME/CFS Collaborative Research Centre at, Uppsala University, Uppsala, Sweden; Harvard Medical School, Immune and Metabolic Computational Center, Massachusetts General Hospital, Boston, MA, USA; Open Medicine Foundation ME/CFS Collaborative Research Center at Harvard, Massachusetts General Hospital, Boston, MA, USA; Patient-Partner, ICanCME Research Network, Azrieli Research Center, CHU Sainte-Justine, Montreal, QC, Canada; TOPO-Laboratories, Montreal, QC, Canada; Department of Stomatology, Faculty of Dentistry, Universit√© de Montr√©al, Montreal, Canada.
- **Publisher:** Journal of Translational Medicine
- **Link:** [DOI](https://doi.org/10.1186/s12967-025-07006-z)

</details>


## Summary

This study provides the first evidence linking a specific genetic trait‚Äîthe type of haptoglobin protein a person has‚Äîto the severity of post-exertional malaise and cognitive dysfunction in ME. It suggests that exertion triggers a stress response in ME patients, possibly involving red blood cell breakdown (hemolysis), and that individuals with less efficient types of haptoglobin (like Hp2-1) are less able to manage this stress, leading to worse symptoms. This research identifies a robust candidate for a PEM biomarker, offers a potential biological explanation for why PEM severity varies between patients, and opens a new avenue for developing targeted therapies, such as supplementing the more protective form of the haptoglobin protein.

## What was researched?

This study investigated the protein haptoglobin (Hp) as a potential biomarker for post-exertional malaise (PEM) and cognitive dysfunction in ME. Researchers examined how different genetic types (phenotypes) and structural forms of Hp are associated with the severity of these hallmark symptoms.

## Why was it researched?

The molecular mechanisms driving PEM and cognitive issues in ME are still unknown. Based on emerging evidence of blood-related abnormalities and oxidative stress in the disease, the researchers hypothesized that haptoglobin, a key protein that protects against damage from hemoglobin released from red blood cells, might play a significant role. This study aimed to explore the link between Hp, PEM, and cognitive impairment.

## How was it researched?

This was a longitudinal case-control study involving a total of 140 ME patients and 44 healthy controls, split into two cohorts. In the first phase, researchers performed proteomic analysis on plasma samples from 61 ME patients and 20 controls before and after a standardized, non-invasive stress test designed to induce PEM. In the second phase, they validated these findings in a separate cohort of 89 ME patients and 24 controls using high-performance liquid chromatography (HPLC) to analyze Hp concentration and structure, and correlated this with symptom severity and cognitive performance data.

## What has been found?

ME patients experienced a significant reduction in haptoglobin (Hp) levels after the stress test, a change not observed in healthy controls. The study revealed a genetic link to symptom severity: the Hp1-1 phenotype was associated with milder symptoms, while the Hp2-1 phenotype was more common in ME patients and linked to more severe PEM and cognitive deficits. Furthermore, ME patients with the Hp2-1 phenotype showed altered structural forms of the protein (an increase in larger oligomers), and the abundance of these forms correlated with PEM severity and cognitive impairment.

## Discussion

The authors highlight the strength of detecting significant Hp differences even after using a standard proteomic preparation step designed to remove it, suggesting that specific, structurally altered forms of Hp are retained and are pathologically relevant in ME. A primary limitation was the small number of patients with the protective Hp1-1 phenotype, which reduced statistical power for some comparisons. The inclusion of severely ill, housebound patients, who are often excluded from research, was noted as a strength, although the authors acknowledge that more time points would be needed to fully capture the dynamics of PEM.

## Conclusion & Future Work

The authors conclude that a person's haptoglobin phenotype and its molecular structure modulate their physiological response to exertion in ME, providing a potential molecular explanation for PEM and its clinical variability. Hp is proposed as a promising biomarker for patient stratification and as a potential therapeutic target. Future work may explore phenotype-informed interventions, such as administering the more protective Hp1-1 form, to mitigate oxidative stress and cognitive dysfunction in genetically susceptible ME patients.
